From: Can apneic oxygen insufflation become a novel lung protective ventilation strategy? A randomized, controlled, blinded, single center clinical trial
NF-kB(pg/ml)
sICAM-1(ng/ml)
IL-6(pg/ml)
IL-10(pg/ml)
Group C
Group T
49.12[36.66–71.33]
33.35[17.11–52.50]c
0.59[0.22–0.71]
0.33[0.23–0.44]c
7.08[4.73–9.28]
3.67[2.15–6.5]c
1.91[0.97–2.40]
2.67[1.49–4.08]c